Literature DB >> 30710377

Complications and reoperations after laparoscopic radical cystectomy in a Japanese multicenter cohort.

Toru Kanno1, Katsuhiro Ito2, Atsuro Sawada3, Ryoich Saito3, Takashi Kobayashi3, Hitoshi Yamada1, Takahiro Inoue3, Osamu Ogawa3.   

Abstract

OBJECTIVES: To describe the complications and their surgical management after laparoscopic radical cystectomy in a Japanese multicenter cohort.
METHODS: The participants were drawn from a retrospective multicenter study at 10 institutions. We identified 436 patients who underwent laparoscopic radical cystectomy with no robot assistance. Early and late complications were graded according to their Clavien-Dindo classification. The records of all patients who underwent surgical interventions for laparoscopic radical cystectomy-specific complications were also reviewed. Kaplan-Meier curves were used to describe the time to surgical intervention.
RESULTS: The 90-day rates for overall complications, high-grade complications (Clavien-Dindo classification III-V) and mortality were 53%, 17% and 1.4%, respectively. Gastrointestinal (25%), infectious (22%) and abdominal wall-related (9%) complications were the most common. The late complication rate was 18%, and a total of 81 patients (19%) underwent surgical intervention during the median follow-up period of 22 months. The reoperation rate was 25% at 5 years. Gastrointestinal complications in the early postoperative period and abdominal wall-related complications in the late postoperative period were the main reasons for reoperation. Seven (7%) out of 100 female patients underwent emergent surgical reoperation for transvaginal bowel evisceration as a result of vaginal dehiscence.
CONCLUSIONS: Early and late postoperative complications and surgical reoperations are notable after laparoscopic radical cystectomy. Abdominal wall-related complications including vaginal dehiscence are common, and they represent the main indication for reoperation during long-term follow up.
© 2019 The Japanese Urological Association.

Entities:  

Keywords:  bladder cancer; complication; laparoscopy; radical cystectomy; reoperation

Mesh:

Year:  2019        PMID: 30710377     DOI: 10.1111/iju.13917

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  7 in total

1.  Vaginal Complications after Cystectomy: Results from a Medicare Sample.

Authors:  Lee A Richter; Oyomoare L Osazuwa-Peters; Jonathan C Routh; Victoria L Handa
Journal:  J Urol       Date:  2021-12-02       Impact factor: 7.450

2.  Vaginal Complications after Radical Cystectomy for Bladder Cancer: A Systematic Review.

Authors:  Lee A Richter; Jillian Egan; Emily C Alagha; Victoria L Handa
Journal:  Urology       Date:  2021-07-17       Impact factor: 2.649

Review 3.  Biomarker-Oriented Therapy in Bladder and Renal Cancer.

Authors:  Mathijs P Scholtes; Arnout R Alberts; Iris G Iflé; Paul C M S Verhagen; Astrid A M van der Veldt; Tahlita C M Zuiverloon
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

4.  Short-term morbidity and mortality following radical cystectomy: a systematic review.

Authors:  Sophia Liff Maibom; Ulla Nordström Joensen; Alicia Martin Poulsen; Henrik Kehlet; Klaus Brasso; Martin Andreas Røder
Journal:  BMJ Open       Date:  2021-04-14       Impact factor: 2.692

5.  Systematic review and meta-analysis on laparoscopic cystectomy in bladder cancer.

Authors:  Jialiang Zhu; Ziwen Lu; Wanbo Chen; Mang Ke; Xianguo Cai
Journal:  Transl Androl Urol       Date:  2022-01

6.  Case of vaginal cuff dehiscence and small bowel evisceration after laparoscopic radical cystectomy.

Authors:  Satoru Meguro; Yusuke Kirihana; Tomoyuki Kumekawa; Masato Kobayashi; Hiroshi Kameoka
Journal:  IJU Case Rep       Date:  2021-07-13

7.  Is it necessary to perform a retrosigmoid transposition of the left ureter in Bricker Ileal Conduit surgery?

Authors:  Jinyou Wang; Zhouting Tuo; Mingzhu Gao; Jie Min; Yi Wang; Tao Zhang; Dexin Yu; Liangkuan Bi
Journal:  BMC Urol       Date:  2022-07-27       Impact factor: 2.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.